+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bone Metabolism Assays - Medical Devices Pipeline Assessment, 2019

  • ID: 4856563
  • Report
  • November 2019
  • Region: Global
  • 40 Pages
  • GlobalData
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Alere Inc
  • AMS Diagnostics LLC
  • Beckman Coulter Inc
  • DiaSorin SpA
  • Novartis AG
  • OJ-Bio Ltd (Inactive)
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Bone Metabolism Assays - Medical Devices Pipeline Assessment, 2019

Summary
The author's Medical Devices sector report, “Bone Metabolism Assays - Medical Devices Pipeline Assessment, 2019 provides an overview of Bone Metabolism Assays currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Metabolism Assays pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by The author's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Bone Metabolism Assays under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bone Metabolism Assays and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy
The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bone Metabolism Assays under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alere Inc
  • AMS Diagnostics LLC
  • Beckman Coulter Inc
  • DiaSorin SpA
  • Novartis AG
  • OJ-Bio Ltd (Inactive)


1 Table of Contents
2 Introduction
2.1 Bone Metabolism Assays Overview
3 Products under Development
3.1 Bone Metabolism Assays - Pipeline Products by Stage of Development
3.2 Bone Metabolism Assays - Pipeline Products by Segment
3.3 Bone Metabolism Assays - Pipeline Products by Territory
3.4 Bone Metabolism Assays - Pipeline Products by Regulatory Path
3.5 Bone Metabolism Assays - Pipeline Products by Estimated Approval Date
4 Bone Metabolism Assays - Pipeline Products under Development by Companies
4.1 Bone Metabolism Assays Companies - Pipeline Products by Stage of Development
4.2 Bone Metabolism Assays - Pipeline Products by Stage of Development
5 Bone Metabolism Assays Companies and Product Overview
5.1 Alere Inc Company Overview
5.1.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 AMS Diagnostics LLC Company Overview
5.2.1 AMS Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.3 Beckman Coulter Inc Company Overview
5.3.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Carolina Liquid Chemistries Corp Company Overview
5.4.1 Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview
5.5 DiaSorin SpA Company Overview
5.5.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview
5.6 Immunodiagnostic Systems Holdings plc Company Overview
5.6.1 Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Novartis AG Company Overview
5.7.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
5.8 OJ-Bio Ltd (Inactive) Company Overview
5.8.1 OJ-Bio Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.9 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview
5.9.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.10 Siemens Healthineers AG Company Overview
5.10.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
5.11 Tosoh Bioscience Inc Company Overview
5.11.1 Tosoh Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Bone Metabolism Assays- Recent Developments
6.1 Mar 07, 2019: Mindray signs patient safety movement’s open data pledge & becomes 90th company to join to improve patient safety
6.2 Dec 04, 2018: Mindray international exchange program on hematology: linking medical expertise across borders
7 Appendix
7.1 Methodology
7.2 About the author
7.3 Contact Us
7.4 Disclaimer
List of Tables
Table 1: Bone Metabolism Assays - Pipeline Products by Stage of Development
Table 2: Bone Metabolism Assays - Pipeline Products by Segment
Table 3: Bone Metabolism Assays - Pipeline Products by Territory
Table 4: Bone Metabolism Assays - Pipeline Products by Regulatory Path
Table 5: Bone Metabolism Assays - Pipeline Products by Estimated Approval Date
Table 6: Bone Metabolism Assays Companies - Pipeline Products by Stage of Development
Table 7: Bone Metabolism Assays - Pipeline Products by Stage of Development
Table 8: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 11: AMS Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 24: DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
Table 37: OJ-Bio Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Tosoh Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Glossary
List of Figures
Figure 1: Bone Metabolism Assays - Pipeline Products by Stage of Development
Figure 2: Bone Metabolism Assays - Pipeline Products by Segment
Figure 3: Bone Metabolism Assays - Pipeline Products by Territory
Figure 4: Bone Metabolism Assays - Pipeline Products by Regulatory Path
Figure 5: Bone Metabolism Assays - Pipeline Products by Estimated Approval Date
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Alere Inc
  • AMS Diagnostics LLC
  • Beckman Coulter Inc
  • Carolina Liquid Chemistries Corp
  • DiaSorin SpA
  • Immunodiagnostic Systems Holdings plc
  • Novartis AG
  • OJ-Bio Ltd (Inactive)
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Siemens Healthineers AG
  • Tosoh Bioscience Inc
Note: Product cover images may vary from those shown